Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Filippo de Marinis"'
Autor:
Filippo de Marinis, Chiara Catania, Cristina Noberasco, Chiara Lazzari, Massimo Barberis, Gianluca Spitaleri, Viviana Stufano, Tommaso De Pas, Fabio Vecchio, Francesca Toffalorio, Fabio Conforti
Publikováno v:
Journal of Thoracic Oncology. (2):392-396
Background More than even before, the efficacy of epidermal growth factors (EGFRs) tyrosine kinase inhibitors in non–small-cell lung cancer patients carrying EGFR wild-type tumors has been under investigation. EGFR wild-type patients represent a la
Autor:
Tarini Prasad Sahoo, Olivier Molinier, Annamaria Zimmermann, Martin Reck, E. Laack, Luis Paz-Ares, Filippo de Marinis, William J. John, Cesare Gridelli, Carla Visseren-Grul
Publikováno v:
Journal of Thoracic Oncology
Introduction: The PARAMOUNT phase III trial demonstrated that pemetrexed continuation maintenance significantly reduced the risk of disease progression (hazard ratio = 0.62) and death (hazard ratio = 0.78) versus placebo in patients with advanced non
Autor:
Francesco Perrone, Filippo de Marinis, John V. Heymach, Nick Thatcher, Fortunato Ciardiello, Johan Vansteenkiste, Andrea Ardizzoni, Luigi De Petris, Cesare Gridelli, Nasser H. Hanna, Frances A. Shepherd, Massimo Di Maio, Rafael Rosell
Publikováno v:
Journal of Thoracic Oncology. (4):430-440
After failure of first-line chemotherapy for advanced non-small cell lung cancer, many patients remain candidates to receive further antitumor treatment. To guide clinical management of these patients and to suggest priorities for clinical research,
Autor:
Silvia Novello, M. Nardi, M. Rinaldi, Angelo Tinazzi, Giorgio V. Scagliotti, Filippo de Marinis, Simona Rossi, Carmelo Tibaldi, Francesca Russo, Lucio Crinò
Publikováno v:
Journal of Thoracic Oncology. (8):S687-S688